author-photo

Jeffrey C. Hanselman

Esperion Therapeutics Inc.

13

Papers

774

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial

2020 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (9)
Measuring vs Estimating LDL-C Levels in a Clinical Trial of Bempedoic Acid-Reply.

2020 JAMA
Show All
- Source
- Cite
- Save
Citations (0)
Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial

2019 Journal of Clinical Lipidology
Show All
- Source
- Cite
- Save
Citations (25)
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial

2019 JAMA
Show All
- Source
- Cite
- Save
Citations (123)
Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

2016 Journal of Clinical Lipidology
Show All
- Source
- Cite
- Save
Citations (76)
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism

2013 Journal of Lipid Research
Show All
- Source
- Cite
- Save
Citations (119)
AMP-activated Protein Kinase: An Emerging Drug Target to Regulate Imbalances in Lipid and Carbohydrate Metabolism to Treat Cardio- Metabolic Diseases

2012 Journal of Lipid Research
Show All
- Source
- Cite
- Save
Citations (183)